239 related articles for article (PubMed ID: 32317022)
21. Skeletal muscle transcriptional networks linked to type I myofiber grouping in Parkinson's disease.
Lavin KM; Sealfon SC; McDonald MN; Roberts BM; Wilk K; Nair VD; Ge Y; Lakshman Kumar P; Windham ST; Bamman MM
J Appl Physiol (1985); 2020 Feb; 128(2):229-240. PubMed ID: 31829804
[TBL] [Abstract][Full Text] [Related]
22. RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson's disease.
Craig DW; Hutchins E; Violich I; Alsop E; Gibbs JR; Levy S; Robison M; Prasad N; Foroud T; Crawford KL; Toga AW; Whitsett TG; Kim S; Casey B; Reimer A; Hutten SJ; Frasier M; Kern F; Fehlman T; Keller A; Cookson MR; Van Keuren-Jensen K;
Nat Aging; 2021 Aug; 1(8):734-747. PubMed ID: 37117765
[TBL] [Abstract][Full Text] [Related]
23. Molecular changes in the postmortem parkinsonian brain.
Toulorge D; Schapira AH; Hajj R
J Neurochem; 2016 Oct; 139 Suppl 1():27-58. PubMed ID: 27381749
[TBL] [Abstract][Full Text] [Related]
24. Molecular Features Underlying Neurodegeneration Identified through In Vitro Modeling of Genetically Diverse Parkinson's Disease Patients.
Lin L; Göke J; Cukuroglu E; Dranias MR; VanDongen AM; Stanton LW
Cell Rep; 2016 Jun; 15(11):2411-26. PubMed ID: 27264186
[TBL] [Abstract][Full Text] [Related]
25. Analysis of Mitochondrial haemoglobin in Parkinson's disease brain.
Shephard F; Greville-Heygate O; Liddell S; Emes R; Chakrabarti L
Mitochondrion; 2016 Jul; 29():45-52. PubMed ID: 27181046
[TBL] [Abstract][Full Text] [Related]
26. Proteins and Transcriptional Dysregulation of the Brain Extracellular Matrix in Parkinson's Disease: A Systematic Review.
Rike WA; Stern S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108598
[TBL] [Abstract][Full Text] [Related]
27. Cell-Specific RNA Quantification in Human SN DA Neurons from Heterogeneous Post-mortem Midbrain Samples by UV-Laser Microdissection and RT-qPCR.
Duda J; Fauler M; Gründemann J; Liss B
Methods Mol Biol; 2018; 1723():335-360. PubMed ID: 29344870
[TBL] [Abstract][Full Text] [Related]
28. A computational approach to identify blood cell-expressed Parkinson's disease biomarkers that are coordinately expressed in brain tissue.
Moni MA; Rana HK; Islam MB; Ahmed MB; Xu H; Hasan MAM; Lei Y; Quinn JMW
Comput Biol Med; 2019 Oct; 113():103385. PubMed ID: 31437626
[TBL] [Abstract][Full Text] [Related]
29. Single-cell brain atlas of Parkinson's disease mouse model.
Zhong J; Tang G; Zhu J; Wu W; Li G; Lin X; Liang L; Chai C; Zeng Y; Wang F; Luo L; Li J; Chen F; Huang Z; Zhang X; Zhang Y; Liu H; Qiu X; Tang S; Chen D
J Genet Genomics; 2021 Apr; 48(4):277-288. PubMed ID: 34052184
[TBL] [Abstract][Full Text] [Related]
30. Unraveling the transcriptomic signatures of Parkinson's disease and major depression using single-cell and bulk data.
Christodoulou CC; Onisiforou A; Zanos P; Papanicolaou EZ
Front Aging Neurosci; 2023; 15():1273855. PubMed ID: 38020762
[TBL] [Abstract][Full Text] [Related]
31. LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to
Weindel CG; Bell SL; Vail KJ; West KO; Patrick KL; Watson RO
Elife; 2020 Feb; 9():. PubMed ID: 32057291
[TBL] [Abstract][Full Text] [Related]
32. The 4p16.3 Parkinson Disease Risk Locus Is Associated with GAK Expression and Genes Involved with the Synaptic Vesicle Membrane.
Nagle MW; Latourelle JC; Labadorf A; Dumitriu A; Hadzi TC; Beach TG; Myers RH
PLoS One; 2016; 11(8):e0160925. PubMed ID: 27508417
[TBL] [Abstract][Full Text] [Related]
33. Computational deconvolution of genome wide expression data from Parkinson's and Huntington's disease brain tissues using population-specific expression analysis.
Capurro A; Bodea LG; Schaefer P; Luthi-Carter R; Perreau VM
Front Neurosci; 2014; 8():441. PubMed ID: 25620908
[TBL] [Abstract][Full Text] [Related]
34. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC
J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496
[TBL] [Abstract][Full Text] [Related]
35. Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers.
Zhao Y; Perera G; Takahashi-Fujigasaki J; Mash DC; Vonsattel JPG; Uchino A; Hasegawa K; Jeremy Nichols R; Holton JL; Murayama S; Dzamko N; Halliday GM
Brain; 2018 Feb; 141(2):486-495. PubMed ID: 29253086
[TBL] [Abstract][Full Text] [Related]
36. Parkinson's disease genetic risk in a midbrain neuronal cell line.
Pierce SE; Tyson T; Booms A; Prahl J; Coetzee GA
Neurobiol Dis; 2018 Jun; 114():53-64. PubMed ID: 29486295
[TBL] [Abstract][Full Text] [Related]
37. Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes.
Santiago JA; Potashkin JA
PLoS One; 2013; 8(12):e83940. PubMed ID: 24376773
[TBL] [Abstract][Full Text] [Related]
38. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
39. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
[TBL] [Abstract][Full Text] [Related]
40. Sensitive and Low-Bias Transcriptome Sequencing Using Agarose PCR.
Zhou Y; Jia E; Sheng Y; Qiao Y; Wang Y; Shi H; Liu Z; Pan M; Tu J; Bai Y; Zhao X; Ge Q; Lu Z
ACS Appl Mater Interfaces; 2022 May; 14(17):19154-19167. PubMed ID: 35446027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
